Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022
March 22 2022 - 6:35AM
Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset, multi-modality
company focused on developing next-generation therapeutics for
difficult to treat cancers, today announced it will host a
conference call and live webcast on Tuesday, March 29, 2022 at 8:00
a.m. ET to discuss recent corporate updates.
The live event may be accessed as follows:
Pyxis Corporate Update Conference Call and
Webcast:
Teleconference: |
|
(833) 945-2461
(domestic) or (520) 809-9726 (international) |
|
Conference ID 5458057 |
Webcast |
|
https://edge.media-server.com/mmc/p/c8uwd9dr |
The webcast can also be accessed on the Investors
section of the Pyxis Oncology website at ir.pyxisoncology.com. A
replay of the webcast will be available approximately two hours
after completion of the call and will be archived on the Company’s
website for up to 90 days.
About Pyxis Oncology, Inc.Pyxis
Oncology, Inc. is a multi-asset, multi-modality company focused on
defeating difficult to treat cancers and improve patient lives. By
leveraging our fully integrated research, development and
commercial capabilities, our expert team is efficiently building a
diversified portfolio of next-generation therapeutics. Pyxis
Oncology’s therapeutic candidates are designed to directly kill
tumor cells, and to address the underlying pathologies created by
cancer that enable its uncontrollable proliferation and immune
evasion. Since its launch in 2019, Pyxis Oncology has developed a
broad portfolio of novel antibody drug conjugate, or ADC, product
candidates, and monoclonal antibody, or mAb, preclinical discovery
programs that it is developing as monotherapies and in combination
with other therapies. To learn more about Pyxis Oncology visit
www.pyxisoncology.com.
Pyxis Investor/Media Contact:
Courtney Dugan VP, Investor Relations and Corporate
Communicationsir@pyxisoncology.com
Pyxis Oncology (NASDAQ:PYXS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pyxis Oncology (NASDAQ:PYXS)
Historical Stock Chart
From Sep 2023 to Sep 2024